Cargando…

Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche

We previously reported a new approach for culturing difficult-to-preserve primary patient-derived multiple myeloma cells (MMC) using an osteoblast (OSB)-derived 3D tissue scaffold constructed in a perfused microfluidic environment and a culture medium supplemented with patient plasma. In the current...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenting, Gu, Yexin, Sun, Qiaoling, Siegel, David S., Tolias, Peter, Yang, Zheng, Lee, Woo Y., Zilberberg, Jenny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431864/ https://www.ncbi.nlm.nih.gov/pubmed/25973790 http://dx.doi.org/10.1371/journal.pone.0125995

Ejemplares similares

Ex vivo 3D osteocyte network construction with primary murine bone cells
por: Sun, Qiaoling, et al.
Publicado: (2015)

Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production
por: Uhl, Christopher, et al.
Publicado: (2022)

Microfluidic device engineered to study the trafficking of multiple myeloma cancer cells through the sinusoidal niche of bone marrow
por: Sui, Chao, et al.
Publicado: (2022)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization
por: Chen, Zheng, et al.
Publicado: (2018)

Maintenance therapy in multiple myeloma
por: Harousseau, Jean-Luc
Publicado: (2009)

Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
por: Lee, Ho Sup, et al.
Publicado: (2016)

Droplet Microfluidics for the ex Vivo Expansion of Human Primary Multiple Myeloma Cells
por: Carreras, Pilar, et al.
Publicado: (2020)

Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma
por: Iannozzi, Nicolas Thomas, et al.
Publicado: (2022)

Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
por: Choudhary, Saba, et al.
Publicado: (2018)

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma
por: Kinder, Michelle, et al.
Publicado: (2021)

Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
por: Chillemi, Antonella, et al.
Publicado: (2017)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

The role of maintenance therapy in multiple myeloma
por: Lipe, B, et al.
Publicado: (2016)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma
por: Papadimitriou, Konstantinos, et al.
Publicado: (2020)

Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically
por: Giliberto, Mariaserena, et al.
Publicado: (2022)

Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
por: Kropivsek, Klara, et al.
Publicado: (2023)

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo
por: Weiss, C, et al.
Publicado: (2012)

Bone marrow niche in multiple myeloma and its precursor states
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2019)

Future Directions in Maintenance Therapy in Multiple Myeloma
por: Holstein, Sarah A., et al.
Publicado: (2021)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
por: Adamik, Juraj, et al.
Publicado: (2019)

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
por: Lungu, Oxana, et al.
Publicado: (2023)

Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2014)

Multiple myeloma-derived exosomes inhibit osteoblastic differentiation and improve IL-6 secretion of BMSCs from multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2020)

Intercellular transfer to signaling endosomes regulates an ex vivo bone marrow niche
por: Gillette, Jennifer M., et al.
Publicado: (2009)

Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma
por: Foureau, David M., et al.
Publicado: (2020)

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
por: Huang, Beihui, et al.
Publicado: (2023)

Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

PB1966: HEMOPOIETIC NICHE IMPAIRMENT IN TREATED MULTIPLE MYELOMA PATIENTS
por: Semenova, N. Y., et al.
Publicado: (2022)

Role of the Osteoblast Lineage in the Bone Marrow Hematopoietic Niches
por: Wu, Joy Y, et al.
Publicado: (2009)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Posttransplant maintenance therapy in multiple myeloma: the changing landscape
por: Sengsayadeth, S, et al.
Publicado: (2017)

Post-Transplant Maintenance Treatment Options in Multiple Myeloma
por: Karam, Dhauna, et al.
Publicado: (2021)

The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
por: Tariq, Syed Maaz, et al.
Publicado: (2023)

Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease
por: Peng, Fengping, et al.
Publicado: (2022)

Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma
por: Waldschmidt, Johannes M., et al.
Publicado: (2022)

Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche
por: Gaudichon, Jérémie, et al.
Publicado: (2014)

Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
por: Hu, Jinsong, et al.
Publicado: (2012)

The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upil1l8g5fkpdmvm0tjba1koi2